688276 百克生物
已收盘 08-20 15:00:01
资讯
新帖
简况
图解百克生物中报：第二季度单季净利润同比增长34.85%
证券之星 · 01:55
图解百克生物中报：第二季度单季净利润同比增长34.85%
股市必读：百克生物（688276）登8月20日交易所龙虎榜
证券之星 · 00:53
股市必读：百克生物（688276）登8月20日交易所龙虎榜
8月20日百克生物创60日新高，金鹰鑫瑞混合A基金重仓该股
证券之星 · 08-20 16:37
8月20日百克生物创60日新高，金鹰鑫瑞混合A基金重仓该股
生物疫苗股全线大涨，康希诺等5股20CM涨停，默沙东莫德纳黑色素瘤疫苗临床试验传捷报
格隆汇 · 08-20 09:47
生物疫苗股全线大涨，康希诺等5股20CM涨停，默沙东莫德纳黑色素瘤疫苗临床试验传捷报
每周股票复盘：百克生物（688276）将召开2026年半年度业绩说明会
证券之星 · 08-16
每周股票复盘：百克生物（688276）将召开2026年半年度业绩说明会
股市必读：百克生物新发布《长春百克生物科技股份公司关于召开2026年半年度业绩说明会的公告》
证券之星 · 08-14
股市必读：百克生物新发布《长春百克生物科技股份公司关于召开2026年半年度业绩说明会的公告》
百克生物（688276）披露2026年半年度业绩说明会公告，8月12日股价下跌1.01%
证券之星 · 08-12
百克生物（688276）披露2026年半年度业绩说明会公告，8月12日股价下跌1.01%
股市必读：百克生物（688276）7月24日披露最新机构调研信息
证券之星 · 07-27
股市必读：百克生物（688276）7月24日披露最新机构调研信息
每周股票复盘：百克生物（688276）液体剂型获批将供货
证券之星 · 07-26
每周股票复盘：百克生物（688276）液体剂型获批将供货
百克生物：7月24日组织现场参观活动，东海证券、北京峰谷资本管理有限公司等多家机构参与
证券之星 · 07-24
百克生物：7月24日组织现场参观活动，东海证券、北京峰谷资本管理有限公司等多家机构参与
百克生物：将持续完善人才激励机制
证券之星 · 07-24
百克生物：将持续完善人才激励机制
百克生物获得发明专利授权：“一种6-甲基-3,5-二氧代辛酰辅酶A及其制备方法和应用”
证券之星 · 07-22
百克生物获得发明专利授权：“一种6-甲基-3,5-二氧代辛酰辅酶A及其制备方法和应用”
股市必读：百克生物（688276）7月3日董秘有最新回复
证券之星 · 07-06
股市必读：百克生物（688276）7月3日董秘有最新回复
每周股票复盘：百克生物（688276）归还8,486.49万元募资并再用5,000万元补流
证券之星 · 07-05
每周股票复盘：百克生物（688276）归还8,486.49万元募资并再用5,000万元补流
百克生物：公司在研项目阿尔茨海默病治疗性疫苗处于临床前研究阶段
证券之星 · 07-03
百克生物：公司在研项目阿尔茨海默病治疗性疫苗处于临床前研究阶段
百克生物（688276）披露归还前次临时补流募集资金并拟再使用不超5000万元闲置募集资金临时补充流动资金，6月30日股价下跌2.86%
证券之星 · 06-30
百克生物（688276）披露归还前次临时补流募集资金并拟再使用不超5000万元闲置募集资金临时补充流动资金，6月30日股价下跌2.86%
股市必读：百克生物（688276）6月26日董秘有最新回复
证券之星 · 06-29
股市必读：百克生物（688276）6月26日董秘有最新回复
百克生物：阿尔茨海默病治疗性疫苗处于临床前研究阶段
证券之星 · 06-26
百克生物：阿尔茨海默病治疗性疫苗处于临床前研究阶段
股市必读：百克生物（688276）6月18日董秘有最新回复
证券之星 · 06-22
股市必读：百克生物（688276）6月18日董秘有最新回复
百克生物：系统推进多项营销举措
证券之星 · 06-18
百克生物：系统推进多项营销举措
公司概况
公司名称：
长春百克生物科技股份公司
所属行业：
医药制造业
上市日期：
2021-06-25
主营业务：
长春百克生物科技股份公司的主营业务是传染病防治的创新生物药的研发、生产及销售。公司的主要产品是水痘疫苗、鼻喷流感疫苗、带状疱疹疫苗、液体鼻喷流感疫苗。
发行价格：
36.35
{"stockData":{"symbol":"688276","market":"SH","secType":"STK","nameCN":"百克生物","latestPrice":18.71,"timestamp":1787209201000,"preClose":15.59,"halted":0,"volume":6489622,"delay":0,"changeRate":0.2001,"floatShares":413999999,"shares":413999999,"eps":-0.6458,"marketStatus":"已收盘","change":3.12,"latestTime":"08-20 15:00:01","open":18.71,"high":18.71,"low":18.71,"amount":121000000,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":18.71,"bidSize":34934,"shortable":0,"etf":0,"ttmEps":-0.6458,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787275800000},"marketStatusCode":5,"adr":0,"adjPreClose":15.59,"symbolType":"stock_kcb","openAndCloseTimeList":[[1787189400000,1787196600000],[1787202000000,1787209200000]],"highLimit":17.15,"lowLimit":14.03,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":413657598,"isCdr":false,"pbRate":2.01,"roa":"--","roe":"--","epsLYR":-0.64,"committee":0,"marketValue":7740000000,"turnoverRate":0.0157,"status":0,"afterMarket":{"amount":72969,"volume":3900,"close":18.71,"buyVolume":105661,"sellVolume":0,"time":1787211237746,"indexStatus":"已收盘 08-20 15:30:00","preClose":15.59},"floatMarketCap":7740000000},"requestUrl":"/m/hq/s/688276/wiki","defaultTab":"wiki","newsList":[{"id":"2661239233","title":"图解百克生物中报：第二季度单季净利润同比增长34.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661239233","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661239233?lang=zh_cn&edition=full","pubTime":"2026-08-21 01:55","pubTimestamp":1787248517,"startTime":"0","endTime":"0","summary":"证券之星消息，百克生物2026年中报显示，上半年度公司主营收入3.05亿元，同比上升6.89%；归母净利润-5210.01万元，同比上升29.19%；扣非净利润-5351.59万元，同比上升34.92%；其中2026年第二季度，公司单季度主营收入1.57亿元，同比上升28.19%；单季度归母净利润-4862.6万元，同比上升34.85%；单季度扣非净利润-4850.85万元，同比上升38.46%；负债率26.05%，投资收益-2063.41万元，财务费用222.03万元，毛利率78.42%。财报数据概要请见下图:本文数据来源于百克生物2026年中报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100001366.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661005236","title":"股市必读：百克生物（688276）登8月20日交易所龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2661005236","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661005236?lang=zh_cn&edition=full","pubTime":"2026-08-21 00:53","pubTimestamp":1787244787,"startTime":"0","endTime":"0","summary":"截至2026年8月20日收盘，百克生物报收于18.71元，上涨20.01%，涨停，换手率1.57%，成交量6.49万手，成交额1.21亿元。当日关注点交易信息汇总：8月20日主力资金净流入3818.3万元，占总成交额31.45%。交易信息汇总：百克生物因日收盘价格涨幅达15%登上沪深交易所龙虎榜，为近5个交易日内首次上榜。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100000858.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688276","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660402433","title":"8月20日百克生物创60日新高，金鹰鑫瑞混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2660402433","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660402433?lang=zh_cn&edition=full","pubTime":"2026-08-20 16:37","pubTimestamp":1787215049,"startTime":"0","endTime":"0","summary":"证券之星消息，8月20日百克生物涨20.01%创60日新高，收盘报18.71元，换手率1.57%，成交量6.49万手，成交额1.21亿元。重仓百克生物的公募基金请见下表：该股最近90天内共有1家机构给出评级，买入评级1家。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为金鹰基金的金鹰鑫瑞混合A。金鹰鑫瑞混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082000028861.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660727484","title":"生物疫苗股全线大涨，康希诺等5股20CM涨停，默沙东莫德纳黑色素瘤疫苗临床试验传捷报","url":"https://stock-news.laohu8.com/highlight/detail?id=2660727484","media":"格隆汇","labels":["productRelease","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660727484?lang=zh_cn&edition=full","pubTime":"2026-08-20 09:47","pubTimestamp":1787190439,"startTime":"0","endTime":"0","summary":"8月20日，A股市场生物疫苗股全线大涨，其中，百克生物、康希诺、沃森生物、莱美药业、智飞生物20CM涨停，康华生物逼近20CM涨停，康泰生物涨超17%，华兰疫苗涨超10%，德展健康、双鹭药业、海普瑞、海欣股份、万泰生物10CM涨停，金迪克、博晖创新涨超7%，西藏药业、卫光生物、利德曼、冠昊生物、塞力医疗、赛升药业、申联生物、欧林生物涨超6%。消息面上，默沙东与莫德纳周三宣布，联合研发的黑色素瘤皮肤癌疫苗在首次晚期临床试验中取得积极初步结果。\n\n港股频道更多独家策划、专家专栏，免费查阅>>\n\n 责任编辑：栎树","market":"hk","thumbnail":"http://imgcloud.jrjimg.cn/2026/08/cms_20260820094719181.jpg","type":0,"news_type":0,"thumbnails":["http://imgcloud.jrjimg.cn/2026/08/cms_20260820094719181.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2026/08/20094758182842.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["IE00BLSP4239.USD","688185","IE0009355771.USD","LU0689626769.HKD","LU2491050071.SGD","BK4501","LU2023250843.SGD","LU0098860793.USD","301207","LU0861579265.USD","LU0942090050.USD","LU1989772840.SGD","XLV","LU0130102774.USD","LU1571399168.USD","LU1023059063.AUD","BK0077","IE00BJJMRZ35.SGD","LU0211331839.USD","LU1989771016.USD","LU1585245621.USD","LU0868494617.USD","LU0965509283.SGD","BK4550","LU0234572021.USD","LU0965508806.USD","LU2023250504.SGD","LU1066051498.USD","SG9999001440.SGD","LU1064131003.USD","LU2125909593.SGD","LU1291159041.SGD","LU1941712348.USD","LU2361044865.SGD","IE00BN8TJ469.HKD","LU0124676726.USD","VHT","LU1061106388.HKD","FTXH","LU1037948897.HKD","BK4139","LU1066051225.USD","LGHT","LU2148510915.USD","IE00BJT1NW94.SGD","HRTS","LU0859254822.USD","IE00B2B36J28.USD","LU2361045086.USD","LU1064130708.USD","IDNA","LU0070302665.USD","RXL","BK4585","LU1430594728.SGD","LU1057294990.SGD","LU1917777945.USD","LU0965509010.AUD","BK4588","LU1093756168.USD","LU0265550359.USD","LU0006306889.USD","LU0122379950.USD","GDOC","LU1116320737.USD","BK4568","LU1069347547.HKD","BK4551","LU0320765646.SGD","LU1699723380.USD","LU2361044949.HKD","SGXZ57979304.SGD","TRUH","JDOC","LU2491050154.USD","300142","BK0196","LU0985320562.USD","LU2106854487.HKD","LU2580892862.HKD","SG9999014567.USD","LU1989772923.USD","LU2491049909.HKD","LU1934455863.HKD","FHLC","LU1116320901.HKD","300122","IE00B4R5TH58.HKD","LU2089984988.USD","MRNX","06185","SG9999014559.SGD","LU0868494708.USD","BK4533","LU1066053197.SGD","LU0823416689.USD","LU0203347892.USD","LU1328615791.USD","LU2357627491.SGD","IXJ","LU0266013472.USD","LU2125154778.USD","LU2125154935.USD","SG9999015358.SGD","LU2433249047.HKD","LU0208291251.USD","SG9999001176.SGD","LU1934455194.USD","WDNA","SG9999002232.USD","SG9999014542.SGD","LU0289739699.SGD","LU1066051811.HKD","LU2324357040.USD","688276","LU1941712264.USD","MRNA","LU0432979614.USD","LU2112291526.USD","LU0980610538.SGD","IE00BBT3K403.USD","PPH","LU0130517989.USD","PAWZ","SG9999001176.USD","BK0239","SG9999013999.USD","LU0477156953.USD","LU1035773651.USD","IE00B1BXHZ80.USD","BK4534","LU1929549753.HKD","LU1093756325.SGD","LU0648001328.SGD","SG9999002224.SGD","BK4548","IE00BSNM7G36.USD","BK4516","GNOM","IHE","LU1162221912.USD","LU1923622614.USD","BK0070","300006","LU1934455277.USD","LU2360032135.SGD","SG9999015341.SGD","IE0002141913.USD","LU0320765489.SGD","LU0203345920.USD","LU0058720904.USD","BK4559","LU0965509101.SGD","BK0188","LU1974910355.USD","LU0265550946.USD","LU2125909247.SGD","LU2580892789.USD","MRNY","LU2468319806.SGD","LU0106261372.USD","LU1983299246.USD","IE00BFTCPJ56.SGD","MRK","SG9999014575.USD","IE00BLSP4452.SGD","IYH","BK0046","BK4532","LU2461242641.AUD","LU0238689110.USD","LU1037948541.HKD","LU1201861249.SGD","IE000M9KFDE8.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659176681","title":"每周股票复盘：百克生物（688276）将召开2026年半年度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2659176681","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659176681?lang=zh_cn&edition=full","pubTime":"2026-08-16 03:00","pubTimestamp":1786820441,"startTime":"0","endTime":"0","summary":"截至2026年8月14日收盘，百克生物报收于15.97元，较上周的15.61元上涨2.31%。本周，百克生物8月14日盘中最高价报16.29元。百克生物当前最新总市值66.06亿元，在生物制品板块市值排名37/51，在两市A股市值排名2564/5207。公司公告汇总长春百克生物科技股份公司将于2026年8月21日09:00-10:00通过上证路演中心网络互动方式召开2026年半年度业绩说明会，介绍公司经营成果及财务状况。投资者可于2026年8月14日至8月20日16:00前通过上证路演中心网站或公司邮箱ir@bchtpharm.com提交问题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081600000842.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688276","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659444161","title":"股市必读：百克生物新发布《长春百克生物科技股份公司关于召开2026年半年度业绩说明会的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2659444161","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659444161?lang=zh_cn&edition=full","pubTime":"2026-08-14 02:21","pubTimestamp":1786645271,"startTime":"0","endTime":"0","summary":"截至2026年8月13日收盘，百克生物报收于15.96元，上涨1.33%，换手率0.7%，成交量2.88万手，成交额4596.35万元。公司公告汇总：百克生物将于2026年8月21日召开2026年半年度业绩说明会，副董事长孔维、董事总经理姜春来等高管将出席。公司公告汇总长春百克生物科技股份公司关于召开2026年半年度业绩说明会的公告长春百克生物科技股份公司将于2026年8月21日09:00-10:00通过上证路演中心网络互动方式召开2026年半年度业绩说明会，介绍公司经营成果及财务状况。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081400001435.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658973446","title":"百克生物（688276）披露2026年半年度业绩说明会公告，8月12日股价下跌1.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658973446","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658973446?lang=zh_cn&edition=full","pubTime":"2026-08-12 17:33","pubTimestamp":1786527193,"startTime":"0","endTime":"0","summary":"截至2026年8月12日收盘，百克生物报收于15.75元，较前一交易日下跌1.01%，最新总市值为65.15亿元。该股当日开盘15.8元，最高16.06元，最低15.68元，成交额达2966.41万元，换手率为0.45%。公告显示，公司将于2026年8月21日09:00-10:00通过上证路演中心网络互动方式召开2026年半年度业绩说明会，介绍公司经营成果及财务状况。投资者可于2026年8月14日至8月20日16:00前通过上证路演中心网站或公司邮箱ir@bchtpharm.com提交问题。说明会后可通过该平台查看会议内容。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200029949.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654064673","title":"股市必读：百克生物（688276）7月24日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2654064673","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654064673?lang=zh_cn&edition=full","pubTime":"2026-07-27 02:05","pubTimestamp":1785089115,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘，百克生物报收于13.92元，下跌3.06%，换手率0.41%，成交量1.71万手，成交额2401.39万元。当日关注点交易信息汇总：7月24日主力资金净流入235.31万元，散户资金净流出251.75万元。公司流感疫苗扩大适用人群的III期临床研究于2025年8月正式启动，目前全国各中心有序推进。如有相关计划，公司将根据监管要求及时进行披露，感谢您的关注。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072700001003.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688276","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654574490","title":"每周股票复盘：百克生物（688276）液体剂型获批将供货","url":"https://stock-news.laohu8.com/highlight/detail?id=2654574490","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654574490?lang=zh_cn&edition=full","pubTime":"2026-07-26 02:49","pubTimestamp":1785005349,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘，百克生物报收于13.92元，较上周的14.74元下跌5.56%。本周，百克生物7月20日盘中最高价报15.0元。百克生物当前最新总市值57.58亿元，在生物制品板块市值排名37/51，在两市A股市值排名2584/5200。参考目前国家对流感防控的要求和政策支持，公司将结合市场情况，适当安排生产，保障市场供应。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072600000878.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653208634","title":"百克生物：7月24日组织现场参观活动，东海证券、北京峰谷资本管理有限公司等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2653208634","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653208634?lang=zh_cn&edition=full","pubTime":"2026-07-24 18:31","pubTimestamp":1784889072,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年7月24日百克生物发布公告称公司于2026年7月24日组织现场参观活动，东海证券、北京峰谷资本管理有限公司、吉林烁德富家能源科技有限公司、吉林省安华通信集团有限公司、投资者、中国银行、中信银行、吉林省信托有限责任公司、吉林省亚东国有资本投资有限公司、吉林省投资基金有限公司、吉林省工业技术研究院集团有限公司、吉林省盛汇基金管理有限公司、长春汽车城国有资本投资运营有限公司参与。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072400033933.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688276","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653070749","title":"百克生物：将持续完善人才激励机制","url":"https://stock-news.laohu8.com/highlight/detail?id=2653070749","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653070749?lang=zh_cn&edition=full","pubTime":"2026-07-24 16:33","pubTimestamp":1784882002,"startTime":"0","endTime":"0","summary":"证券之星消息，百克生物(688276)07月24日在投资者关系平台上答复投资者关心的问题。投资者提问：长春高新都出了股权激励措施了，百克生物什么时候出百克生物回复：尊敬的投资者您好，公司将结合发展战略、经营业绩、人才建设需求，持续完善人才激励机制。如有相关计划，公司将根据监管要求及时进行披露，感谢您的关注。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072400028452.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688276","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653786940","title":"百克生物获得发明专利授权：“一种6-甲基-3,5-二氧代辛酰辅酶A及其制备方法和应用”","url":"https://stock-news.laohu8.com/highlight/detail?id=2653786940","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653786940?lang=zh_cn&edition=full","pubTime":"2026-07-22 05:46","pubTimestamp":1784670415,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示百克生物新获得一项发明专利授权，专利名为“一种6-甲基-3,5-二氧代辛酰辅酶A及其制备方法和应用”，专利申请号为CN202610329207.6，授权日为2026年7月21日。今年以来百克生物新获得专利授权3个。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072200008744.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649619774","title":"股市必读：百克生物（688276）7月3日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2649619774","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649619774?lang=zh_cn&edition=full","pubTime":"2026-07-06 04:57","pubTimestamp":1783285028,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘，百克生物报收于14.84元，上涨1.3%，换手率0.45%，成交量1.87万手，成交额2766.76万元。董秘最新回复投资者： 公司阿尔茨海默病研发进展如果顺利，预计需要几年董秘： 尊敬的投资者您好，公司在研项目阿尔茨海默病治疗性疫苗处于临床前研究阶段。当日关注点交易信息汇总：7月3日主力资金净流出2.91万元，游资资金净流入183.98万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070600001742.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688276","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649780692","title":"每周股票复盘：百克生物（688276）归还8,486.49万元募资并再用5,000万元补流","url":"https://stock-news.laohu8.com/highlight/detail?id=2649780692","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649780692?lang=zh_cn&edition=full","pubTime":"2026-07-05 04:34","pubTimestamp":1783197252,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘，百克生物报收于14.84元，较上周的13.58元上涨9.28%。本周，百克生物7月3日盘中最高价报15.04元。百克生物当前最新总市值61.39亿元，在生物制品板块市值排名36/50，在两市A股市值排名2809/5203。公司公告汇总：拟使用不超过5,000万元闲置募资临时补充流动资金。公司公告汇总长春百克生物科技股份公司已将前次用于临时补充流动资金的募集资金8,486.49万元全部归还至募集资金专用账户。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070500001647.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648165477","title":"百克生物：公司在研项目阿尔茨海默病治疗性疫苗处于临床前研究阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2648165477","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648165477?lang=zh_cn&edition=full","pubTime":"2026-07-03 16:31","pubTimestamp":1783067465,"startTime":"0","endTime":"0","summary":"证券之星消息，百克生物(688276)07月03日在投资者关系平台上答复投资者关心的问题。投资者提问：公司阿尔茨海默病研发进展如果顺利，预计需要几年百克生物回复：尊敬的投资者您好，公司在研项目阿尔茨海默病治疗性疫苗处于临床前研究阶段。公司坚持将研发创新作为核心战略，不断完善在成人疫苗、多联多价疫苗、治疗性疫苗等创新产品管线以及mRNA技术等新技术路线的布局，通过持续的技术创新与研发升级，不断强化产品差异化优势，致力于满足不同人群的健康需求，筑牢在疫苗领域的长期竞争力。感谢您的关注。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070300029774.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159646","688276","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647557825","title":"百克生物（688276）披露归还前次临时补流募集资金并拟再使用不超5000万元闲置募集资金临时补充流动资金，6月30日股价下跌2.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647557825","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647557825?lang=zh_cn&edition=full","pubTime":"2026-06-30 22:38","pubTimestamp":1782830297,"startTime":"0","endTime":"0","summary":"截至2026年6月30日收盘，百克生物报收于13.94元，较前一交易日下跌2.86%，最新总市值为57.66亿元。该股当日开盘14.35元，最高14.35元，最低13.72元，成交额达3882.86万元，换手率为0.67%。近日，百克生物披露公告显示，公司已于2026年6月30日将前次临时补充流动资金的8,486.49万元全部归还至募集资金专用账户。公司拟使用‘在研产品研发项目’中不超过5,000万元的闲置募集资金临时补充流动资金，使用期限自董事会审议通过之日起不超过12个月，不影响募投项目正常进行。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026063000047337.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647346847","title":"股市必读：百克生物（688276）6月26日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2647346847","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647346847?lang=zh_cn&edition=full","pubTime":"2026-06-29 05:32","pubTimestamp":1782682335,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘，百克生物报收于13.58元，下跌3.96%，换手率0.52%，成交量2.13万手，成交额2944.32万元。截至目前，公司百白破疫苗（三组分）、狂犬单抗等8项在研产品处于临床试验阶段；Hib疫苗、佐剂流感疫苗等5个项目获得临床批件。当日关注点交易信息汇总：6月26日主力资金净流入129.17万元，游资资金净流出227.96万元，散户资金净流入98.78万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900001716.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646337492","title":"百克生物：阿尔茨海默病治疗性疫苗处于临床前研究阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2646337492","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646337492?lang=zh_cn&edition=full","pubTime":"2026-06-26 16:15","pubTimestamp":1782461738,"startTime":"0","endTime":"0","summary":"证券之星消息，百克生物06月26日在投资者关系平台上答复投资者关心的问题。截至目前，公司百白破疫苗（三组分）、狂犬单抗等8项在研产品处于临床试验阶段；Hib疫苗、佐剂流感疫苗等5个项目获得临床批件。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600029107.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159646","688276","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645779016","title":"股市必读：百克生物（688276）6月18日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2645779016","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645779016?lang=zh_cn&edition=full","pubTime":"2026-06-22 05:15","pubTimestamp":1782076515,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，百克生物报收于14.23元，上涨2.6%，换手率0.83%，成交量3.42万手，成交额4882.45万元。后续如有回购相关计划，公司将严格按照规定及时履行信息披露义务。当日关注点交易信息汇总：6月18日主力资金净流入108.17万元，占总成交额0.0%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062200001774.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688276","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644970552","title":"百克生物：系统推进多项营销举措","url":"https://stock-news.laohu8.com/highlight/detail?id=2644970552","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644970552?lang=zh_cn&edition=full","pubTime":"2026-06-18 16:12","pubTimestamp":1781770336,"startTime":"0","endTime":"0","summary":"证券之星消息，百克生物06月18日在投资者关系平台上答复投资者关心的问题。截至目前，公司百白破疫苗（三组分）、狂犬单抗等8项在研产品处于临床试验阶段；Hib疫苗、佐剂流感疫苗等5个项目获得临床批件，此外，公司持续推进阿尔茨海默病治疗性疫苗等多个研发项目的临床前研究工作。后续如有回购相关计划，公司将严格按照规定及时履行信息披露义务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800026813.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688276"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1787268293651,"stockEarnings":[{"period":"1week","weight":0.1723},{"period":"1month","weight":0.2841},{"period":"3month","weight":0.1117},{"period":"6month","weight":-0.0415},{"period":"1year","weight":-0.2465},{"period":"ytd","weight":-0.008}],"compareEarnings":[{"period":"1week","weight":-0.0059},{"period":"1month","weight":0.0102},{"period":"3month","weight":-0.0509},{"period":"6month","weight":-0.0437},{"period":"1year","weight":0.0365},{"period":"ytd","weight":-0.0164}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"长春百克生物科技股份公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"11599人(较上一季度减少0.95%)","perCapita":"35663股","listingDate":"2021-06-25","address":"吉林省长春市朝阳区高新开发区火炬路1260号","registeredCapital":"41365万元","survey":" 长春百克生物科技股份公司的主营业务是传染病防治的创新生物药的研发、生产及销售。公司的主要产品是水痘疫苗、鼻喷流感疫苗、带状疱疹疫苗、液体鼻喷流感疫苗。","listedPrice":36.35},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百克生物(688276)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百克生物(688276)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百克生物,688276,百克生物股票,百克生物股票老虎,百克生物股票老虎国际,百克生物行情,百克生物股票行情,百克生物股价,百克生物股市,百克生物股票价格,百克生物股票交易,百克生物股票购买,百克生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百克生物(688276)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百克生物(688276)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}